A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients.
Kraoua I, Sedel F, Caillaud C, Froissart R, Stirnemann J, Chaurand G, Flodrops H, Tari S, Gourfinkel-An I, Mathieu S, Belmatoug N, Billette de Villemeur T, Mignot C.
Kraoua I, et al. Among authors: belmatoug n.
Brain Dev. 2011 Feb;33(2):131-9. doi: 10.1016/j.braindev.2010.02.005. Epub 2010 Mar 21.
Brain Dev. 2011.
PMID: 20307947